InferMed Announces successful collaboration with Siemens

InferMed Ltd, the leading global provider of advanced decision support and data capture solutions for clinical research and practice, today announced that they have successfully completed the first year of study in conjunction with Siemens AG and researchers at the Technical University of Munich that enables an immediate, scalable method of automatically transferring data from an EMR to an EDC system, reducing lag time and greatly increasing efficiency.

Historically, the capture of clinical trial data has been labour intensive and error-prone, requiring data to be manually transcribed into a paper case report form or, more recently, entered manually into Internet-based data capture systems. This innovative solution from InferMed and Siemens offers a scalable, automatic transfer of data between the electronic medical record system and MACRO® EDC from InferMed thereby overcoming interoperability challenges previously associated with systems that operate on different technical platforms or work from within distinct business environments.

The pilot implementation was designed at the Technical University of Munich's Frauenklink to create an automatic electronic data transfer platform for two studies focusing on women's health. One of the studies was to evaluate the effectiveness of the various types of chemotherapy on women with breast cancer. The second study was to evaluate the diagnostic value of the use of motion correction algorithms on magnetic resonance imaging (MRI). By using this highly flexible solution, clinicians and research staff were able to automatically view, retrieve and disseminate clean data, while reducing the effort of manually collecting and entering trial data.

Preliminary results of the study show an increase of efficiency for all involved parties. Those improvements include quality improvement resultant from interfaces to all data demonstrating improved data quality and integrated processes leading to improved process quality.

The Technical University of Munich's Medical Center has proved attractive for both researchers and trial sponsors leading to greater numbers of such trials and therefore increased population results, all of which ultimately leads to improved patient care due to the many high-quality trials being conducted there.

Professor Harbeck, Principal Investigator at The Frauenklink commented that "The Technical University of Munich's academic medical center benefits greatly from using data from our existing clinical information system for clinical trial activities and we will continue to explore and use all relevant data sources at the medical center to support our clinical research activities. Complying with national and international data safety regulations, external clinical trial sponsors can now access higher quality data more quickly and in an electronic format."

"Having a solution that significantly improves study efficacy whilst enabling real-time data availability for clinical trial sites can only serve to revolutionise study management" said Duane Lawrence, CEO InferMed Ltd. He continued "enabling adaptive mid-trial alterations and ensuring consistency across study sites will eventually yield more timely and accurate outcomes. We are extremely proud to be part of this innovative solution that will ultimately benefit more timely and personalised patient care."

Dr. Gudrun Zahlmann, the project lead from Siemens AG, Healthcare sector said that "This innovative solution has proven to be efficient in reducing the time effort of the study nurses for data documentation to one third compared to the old paper-based process. All clinical trial related data is available within 24 hours in a high quality, clean format and in accordance with the regulatory requirements. We have found two highly motivated and very reliable partners in the Frauenklinik of the Technical University Munich and in InferMed Ltd. This relationship together with the innovative and challenging solution made this pilot a success. This could prove to be the blueprint for the overall EHR – EDC integration for clinical trials."

About InferMed Ltd
Formed in 1999 InferMed is the leading global provider of advanced decision support and data capture solutions for clinical research and practice. InferMed offers a range of highly innovative software solutions for collecting and managing data. Through both their MACRO EDC application and Arezzo® decision support technology, InferMed’s products are designed to improve patient outcomes and deliver personalised drug and other therapies to healthcare providers. For more information visit www.infermed.com.

About The Technical University of Munich
The Technical University of Munich's Rechts der Isar hospital serves Munich and the world with a highly skilled team of dedicated doctors, nurses, research scientists, and technical assistants. With a workforce of over 3,700 personnel, the University hospital is a renowned center for the care of the sick, for medical research, and for the teaching of medicine. Rechts der Isar comprises more than 31 separate clinics and departments treating some 45,000 inpatients and 160,000 outpatients annually. Its department of obstetrics and gynecology, under the guidance of Prof. Dr. Marion Kiechle and her team is a certified breast center and is heavily involved in clinical research and clinical trials to bring innovative procedures to the patient, such as uPA/PAI measurements for chemotherapy decision support.

A 1,100-bed hospital, Rechts der Isar covers the entire spectrum of modern medicine with state-of-the-art efficiency. Through the close cooperation between healthcare and research, the latest advances in medical techniques can be quickly integrated into patient treatment procedures.

About Siemens Healthcare
Siemens Healthcare is one of the world's largest suppliers to the healthcare industry. The company is a renowned medical solutions provider with core competence and innovative strength in diagnostic and therapeutic technologies as well as in knowledge engineering, including information technology and system integration. With its laboratory diagnostics acquisitions, Siemens Healthcare will be the first fully integrated diagnostics company, bringing together imaging and lab diagnostics, therapy, and healthcare information technology solutions, supplemented by consulting and support services. Siemens Healthcare delivers solutions across the entire continuum of care - from prevention and early detection, to diagnosis, therapy and care. The company employs more than 49,000 people worldwide and operates in 130 countries. In the fiscal year 2007 (Sept. 30), Siemens Healthcare reported sales of €9.85 billion (on a pro forma basis including Dade Behring roughly €11 billion), orders of €10.27 billion, and group profit of €1.32 billion. Further information can be found by visiting http://www.siemens.com/healthcare.

Most Popular Now

Using Data and AI to Create Better Healt…

Academic medical centers could transform patient care by adopting principles from learning health systems principles, according to researchers from Weill Cornell Medicine and the University of California, San Diego. In...

AI Medical Receptionist Modernizing Doct…

A virtual medical receptionist named "Cassie," developed through research at Texas A&M University, is transforming the way patients interact with health care providers. Cassie is a digital-human assistant created by Humanate...

AI Tool Set to Transform Characterisatio…

A multinational team of researchers, co-led by the Garvan Institute of Medical Research, has developed and tested a new AI tool to better characterise the diversity of individual cells within...

Northern Ireland Completes Nationwide Ro…

Go-lives at Western and Southern health and social care trusts mean every pathology service is using the same laboratory information management system; improving efficiency and quality. An ambitious technology project to...

Human-AI Collectives Make the Most Accur…

Diagnostic errors are among the most serious problems in everyday medical practice. AI systems - especially large language models (LLMs) like ChatGPT-4, Gemini, or Claude 3 - offer new ways...

MHP-Net: A Revolutionary AI Model for Ac…

Liver cancer is the sixth most common cancer globally and a leading cause of cancer-related deaths. Accurate segmentation of liver tumors is a crucial step for the management of the...

AI could Help Pathologists Match Cancer …

A new study by researchers at the Icahn School of Medicine at Mount Sinai, Memorial Sloan Kettering Cancer Center, and collaborators, suggests that artificial intelligence (AI) could significantly improve how...

Should AI Chatbots Replace Your Therapis…

The new study exposes the dangerous flaws in using artificial intelligence (AI) chatbots for mental health support. For the first time, the researchers evaluated these AI systems against clinical standards...

AI Detects Early Signs of Osteoporosis f…

Investigators have developed an artificial intelligence-assisted diagnostic system that can estimate bone mineral density in both the lumbar spine and the femur of the upper leg, based on X-ray images...

Forging a Novel Therapeutic Path for Pat…

Rett syndrome is a devastating rare genetic childhood disorder primarily affecting girls. Merely 1 out of 10,000 girls are born with it and much fewer boys. It is caused by...

Mayo Clinic's AI Tool Identifies 9 …

Mayo Clinic researchers have developed a new artificial intelligence (AI) tool that helps clinicians identify brain activity patterns linked to nine types of dementia, including Alzheimer's disease, using a single...

Integrating Care Records is Good. Using …

Opinion Article by Dr Paul Deffley, Chief Medical Officer, Alcidion. A single patient record already exists in the NHS. Or at least, that’s a perception shared by many. A survey of...